Repligen finishes plant expansion and forecasts higher tech revenues in 2015
Repligen has finished an expansion at its US filtration system facility eight months after bolstering its offering in this area by buying a platform from Refine Technology.
Archives for February 13, 2015
GSK invests further in vaccines with $190m buy of GlycoVaxyn
Fresh of its acquisition of Novartis’ vaccine business, GlaxoSmithKline is doubling down with the purchase of GlycoVaxyn AG, a Swiss-based specialist vaccine maker, for $190m (£124m).
Hospira's Remicade copycat up for FDA review as US biosimilars March on
The US FDA has set a date to review its first monoclonal antibody (mAb) biosimilar: a version of J&J’s Remicade marketed by Pfizer takeover target Hospira.